Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albemarle, a developer, manufacturer, and marketer of specialty chemicals for pharmaceuticals, packaging, automotive/transportation, food-safety and custom chemistry services, has reported net sales of $ 592,483 for the second quarter ended June 30, 2010, an increase of 33%, compared to $445,299 for the comparable period in 2009.
Subscribe to our email newsletter
Albemarle has posted a net income of $81,751 for the second quarter 2010, or $0.89 per diluted share, compared to $38,493, or $0.42 per diluted share for the comparable period in 2009. Operating profit was $106,635, compared to $30,991 for the comparable period in 2009.
For the six months ended June 30, 2010, the company has posted a net income of $145,059, or $1.57 per diluted share, compared to $63,892 or $0.70 per diluted share, for the year ago period.
Net sales of $1.17m compared to $931,890 for the year ago period. Operating profit was $182,899, compared to $59,918 for the year ago period.
Mark Rohr, chairman and CEO of Albemarle, said: “For the second consecutive quarter, we achieved record earnings, expanded our margins across all three segments and generated cash flow.”